Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Cardiac Pacemaker Companies

Cardiac pacemaker companies specialize in the design, manufacturing, and distribution of medical devices known as cardiac pacemakers. These devices are crucial in the management of various heart rhythm disorders by regulating the heartbeat through electrical impulses. Typically implanted under the skin near the collarbone, cardiac pacemakers consist of a pulse generator and leads that connect to the heart.

Cardiac Pacemaker CompaniesLatest Cardiac Pacemaker Companies Update



  • July 2023: Abbott declared that the AVEIRâ„¢ dual chamber (DR) leadless pacemaker system, the inaugural dual chamber leadless pacing system globally, has received approval from the U.S. Food and Drug Administration (FDA). This innovation is designed to assist individuals with irregular or sluggish cardiac rhythms. More than 80% of pacemaker-dependent individuals require pacing in both the right atrium and right ventricle. Therefore, the approval expands leadless pacing accessibility for millions of individuals throughout the United States. Now, with the official introduction of dual chamber leadless pacing, the annals of technological advancements in modern medicine that have fundamentally altered the way physicians treat patients are complete. By introducing a genuine dual chamber leadless pacemaker system, Abbott is granting an unprecedented number of individuals access to the advantages of leadless pacing and enhancing our capacity to treat patients with irregular or sluggish cardiac rhythms.




  • May 2023: MicroPort, a multinational corporation specializing in cardiac rhythm management, disclosed that it has obtained approval from the US Food and Drug Administration (FDA) for its most recent line of implantable pacemakers, Alizea and Celea, which are the most durable pacemakers currently available in relation to their size. Additionally, the FDA has granted approval for SmartTouch XT, a tablet-based programmer, SmartView Connect bluetooth home monitor, and Vega pacing leads. Alizea and Cele are equipped with the AutoMRI mode, a MicroPort-developed algorithm that enhances the well-being and security of patients undergoing an MRI procedure. To activate the MRI mode, patients need only consult their cardiologist once within ten days prior to the procedure.


List of Cardiac Pacemaker Companies in the market

  • Sorin Group

  • Abbott Laboratories

  • Pacetronix

  • Biotronik SE & Co. KG

  • Cook Medical

  • Zoll Medical Corporation

  • Boston Scientific Corporation

  • Medtronic P.L.C.

  • Osypca Medical GmbH

  • Medico SpA

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.